We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

106 hedge funds and large institutions have $52.4M invested in Vaxart in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

446% more capital invested

Capital invested by funds: $9.59M → $52.4M (+$42.8M)

355% more call options, than puts

Call options by funds: $273K | Put options by funds: $60K

222% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 9

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

22% more funds holding

Funds holding: 87106 (+19)

12.19% more ownership

Funds ownership: 10.98%23.17% (+12%)

Holders
106
Holders Change
+19
Holders Change %
+21.84%
% of All Funds
1.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
26
Reduced
21
Closed
9
Calls
$273K
Puts
$60K
Net Calls
+$213K
Net Calls Change
+$71K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$20M +$16.1M +15,384,615 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$11M +$1.47M +1,404,391 +20%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$2.85M +$244K +232,897 +12%
Millennium Management
4
Millennium Management
New York
$2.46M +$1.79M +1,711,420 +956%
BlackRock
5
BlackRock
New York
$2.31M -$15.8K -15,118 -0.8%
Goldman Sachs
6
Goldman Sachs
New York
$1.95M +$1.57M +1,498,564 New
Renaissance Technologies
7
Renaissance Technologies
New York
$1.2M +$924K +881,800 +2,075%
Citadel Advisors
8
Citadel Advisors
Florida
$1M +$283K +270,449 +54%
Qube Research & Technologies (QRT)
9
Qube Research & Technologies (QRT)
United Kingdom
$907K +$728K +695,231 +32,840%
State Street
10
State Street
Massachusetts
$759K +$123K +117,200 +25%
Marshall Wace
11
Marshall Wace
United Kingdom
$693K +$559K +533,079 New
HF
12
HRT Financial
New York
$688K +$544K +519,569 +5,191%
Northern Trust
13
Northern Trust
Illinois
$473K +$31K +29,565 +9%
Morgan Stanley
14
Morgan Stanley
New York
$362K -$484K -462,165 -62%
Bank of America
15
Bank of America
North Carolina
$340K +$89.9K +85,782 +49%
Citigroup
16
Citigroup
New York
$326K +$263K +250,869 +8,362,300%
IWM
17
IHT Wealth Management
Illinois
$308K -$990 -945 -0.4%
CSS
18
Cubist Systematic Strategies
Connecticut
$281K -$64.5K -61,586 -22%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$277K +$141K +134,629 +172%
PAS
20
Point72 Asia (Singapore)
Singapore
$270K +$211K +201,146 +2,915%
RJFSA
21
Raymond James Financial Services Advisors
Florida
$261K +$5.66K +5,399 +3%
Squarepoint
22
Squarepoint
New York
$246K +$173K +165,235 +691%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$227K +$70K +66,838 +62%
JF
24
Jump Financial
Illinois
$216K +$174K +166,114 New
Charles Schwab
25
Charles Schwab
California
$200K

VXRT Hedge Fund Activity: Q1 2024 in Review

106 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2024, worth a combined $52.4M — up 446% from $9.59M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new VXRT positions and 9 closed out — a net gain of 20 holders — while 26 added to existing stakes and 21 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $16.1M. The largest seller was Morgan Stanley, cutting an estimated $484K.

  • 106 institutional investors held Vaxart (VXRT) as of Q1 2024, up from 87 in Q4 2023.
  • Funds reported $52.4M of Vaxart stock for Q1 2024, up 446% quarter-over-quarter.
  • 29 funds opened new Vaxart positions in Q1 2024 and 9 closed out, a net change of +20 holders.
  • The largest Vaxart buyer in Q1 2024 was RA Capital Management, an estimated $16.1M added.
  • The largest Vaxart seller in Q1 2024 was Morgan Stanley, an estimated $484K sold.

Based on aggregated 13F filings for Q1 2024.